Evidence map›Paper›PMID 35809564›Full record

ArticleDevelopmental cell2022

Genetic variation associated with condensate dysregulation in disease.

Salman F Banani, Lena K Afeyan, Susana W Hawken, Jonathan E Henninger, Alessandra Dall'Agnese, Victoria E Clark, Jesse M Platt, Ozgur Oksuz, Nancy M Hannett, Ido Sagi and 2 more

Abstract read
In one paragraph

Article in Developmental cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Subcellular localization as a driver of protein function.Nature reviews. Molecular cell biology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Phase Separation in Chromatin Organization and Human Diseases.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Salman F BananiWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Lena K AfeyanWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Susana W HawkenWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Program of Computational & Systems Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Jonathan E HenningerWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Alessandra Dall'AgneseWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Victoria E ClarkWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Jesse M PlattWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Ozgur OksuzWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Nancy M HannettWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Ido SagiWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Tong Ihn LeeWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Richard A YoungWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: young@wi.mit.edu.

Funding

Targeting Genomic Instability and Evolution in MyelomaP01CA155258 · NCI · DANA-FARBER CANCER INST · PI Nikhil C. Munshi · 2011 to 2026
$32.5M
RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITIONT32DK007191 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1986 to 2026
$14.6M
Transcriptional condensates, epigenetic editing and Rett SyndromeR01MH104610 · NIMH · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, YOUNG, RICHARD · 2014 to 2023
$7.4M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Transcriptional regulatory networks in living cellsR01GM123511 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI YOUNG, RICHARD · 2017 to 2020
$3.6M
Oncopathology Training ProgramT32CA251062 · NCI · DANA-FARBER CANCER INST · PI JON C. ASTER, KATHLEEN H BURNS · 2020 to 2026
$2.4M
RNA-mediated Feedback Control of Oncogenic TranscriptionF32CA254216 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI HENNINGER, JONATHAN EDWARD · 2020 to 2022
$206k
Characterizing the Physicochemical Properties of Estrogen Receptor-mediated Transcriptional Condensates in Breast CancerF31CA250171 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI AFEYAN, LENA · 2020 to 2021
$92k
NCI NIH HHS F31 CA250171NCI NIH HHS F32 CA254216NCI NIH HHS P01 CA155258NCI NIH HHS T32 CA251062NIDDK NIH HHS T32 DK007191NIGMS NIH HHS R01 GM123511NIGMS NIH HHS T32 GM087237NIMH NIH HHS R01 MH104610
6 · The paper itself

Abstract

A multitude of cellular processes involve biomolecular condensates, which has led to the suggestion that diverse pathogenic mutations may dysregulate condensates. Although proof-of-concept studies have identified specific mutations that cause condensate dysregulation, the full scope of the pathological genetic variation that affects condensates is not yet known. Here, we comprehensively map pathogenic mutations to condensate-promoting protein features in putative condensate-forming proteins and find over 36,000 pathogenic mutations that plausibly contribute to condensate dysregulation in over 1,200 Mendelian diseases and 550 cancers. This resource captures mutations presently known to dysregulate condensates, and experimental tests confirm that additional pathological mutations do indeed affect condensate properties in cells. These findings suggest that condensate dysregulation may be a pervasive pathogenic mechanism underlying a broad spectrum of human diseases, provide a strategy to identify proteins and mutations involved in pathologically altered condensates, and serve as a foundation for mechanistic insights into disease and therapeutic hypotheses.

Indexed as

ProteinsHumansMutationProteinsbiomolecular condensatescancerclinical geneticscondensate dysregulationhuman geneticsMendelian diseasepathogenic variants

Identifiers

PMID35809564
PMCPMC9339523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.